Another possibility is a triple therapy combining clarithromycine, methronidazolee and a PPI 109, although this treatment is subject to limitations due to resistance to clarithromycine and methronidazolee.
Aunque una limitación de esta última recomendación es la resistencia a claritromicina y metronidazol.